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Abstract
Background: In Parkinson’s disease (PD) population, performing secondary tasks while walking further deteriorates gait
and restrict mobility in functional contexts of daily life. This study (1) analyzed the interference of functional cognitive and
motor secondary task on untrained people with PD and (2) compared their walking with healthy subjects.
Methods: Forty people with PD (aged 66.72 [7.5] years, Hoehn and Yahr stage I-II-III, on-medication) composed the PD
group (PDG) and 43 participants (aged 66.60 [8.75] years) formed the group of healthy counterparts (HG). Gait was
evaluated through spatiotemporal, kinematic and kinetic outcomes in five conditions: single task (ST) and visual, verbal,
auditory and motor dual-task (DT).
Results: The velocity, stride length, and braking force performance of both groups was statistically higher in the ST
condition than in verbal, auditory and motor DT (p< .05), and inferior in double support time and midstance force
(p < .05). The same pattern was observed when compared the ST and visual DT condition, where participants showed a
significantly higher stride length, double support time and braking force in the ST (p< .05). In addition, the PDG exhibited
a significant shorter double support time and midstance force, and showed a higher braking force in the visual DT than in
the verbal DT (p< .05). Similarly, the PDG showed a wider stride in the visual DT than in the motor DT condition (p < .05).
PDG participants had a significantly lower performance than the HG in all the variables analyzed except for the maximum
hip extension in the stance phase (p> .05). Conclusions: In untrained participants with PD, verbal and motor secondary
tasks affect gait significantly, while auditory and visual tasks interfere to a lesser extent. Untrained people with PD have a
poorer gait performance than their healthy counterparts, but in different grades according to the analyzed variables.
Trial registration: The data in this paper are part of a single-blind, randomized, controlled trial and correspond to the
evaluations performed before a physical rehabilitation program, retrospectively registered with the number at clinicaltrial.
gov NCT04038866.
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Background
Parkinson’s disease (PD) is a chronic, progressive and
neurodegenerative pathology, with motor and non-
motor disorders [1], which affects functional mobility
[2]. Still, people with PD report that gait impairments
are the most disabling motor symptoms of the disease
[3]. For this reason, several studies have characterized
gait in people with PD, observing a deterioration of spa-
tiotemporal variables, such as velocity, stride length, ca-
dence and double support time [4, 5].
However, walking in everyday situations is carried out
simultaneously with other activities. This is known as
dual-tasking (DT) and involves the development of two
tasks with different objectives at the same time [6], where
attention is placed in one of the tasks or alternated be-
tween the primary task (gait) and the secondary task (i.e.
cognitive or motor). In the PD population, performing
secondary tasks while walking further deteriorates gait [4]
and restricts walking in functional contexts of daily life.
Despite the amount of published information regarding
how DT affects gait in PD, so far as we know, these studies
do not include kinematic and kinetic variables [5] simultan-
eously to the spatiotemporals, thus preventing a compre-
hensive characterization of the gait pattern or comparisons
with a control group. Also, the majority of studies stress the
importance of the complexity of the secondary task [4] and
use elaborate activities in the evaluation that allow them to
easily see a change in gait such as mathematical calcula-
tions. But there is no consensus on what kind of secondary
task could interfere most [7] (e.g. visual versus verbal), and
daily secondary tasks have not been explored.
Gait assessment with secondary functional tasks, such
as talking with another person or carrying something
with the hands, would allow observing the performance
of people with PD in everyday contexts and guiding
physical therapy with the aim of preparing patients for
these probable challenges. This is of special interest in
PD because the basal ganglia are involved in the control
of different aspects besides motor control [8, 9] and the
onset of cognitive impairment can further impair the
performance of the inevitable daily dual-tasks.
Based on the foregoing, the general objective of the
present study was to analyze the degree of interference of
functional cognitive and motor secondary tasks on the
walking biomechanics in untrained people with Parkinson’s
disease. Likewise, a secondary aim of the study was to com-
pare a parkinsonian walking pattern with gait in healthy
older people during the execution of single and dual-tasks.
Material and methods
Study design and participants
The study design was cross-sectional with a convenience
sample (specifically, modal instance sampling) and ad-
hered to the STROBE guidelines (http://www.strobe-
statement.org/). Eighty-three participants integrated the
sample, of which 40 people with Parkinson’s disease com-
posed the PD group (PDG) and 43 participants formed
the group of healthy counterparts (HG) matched by age,
gender, and height. PDG participants were recruited from
two centers: a Parkinson’s disease Association and the
Neurology Service of a local public hospital. HG individ-
uals were from a Municipal Senior Social Activity Center.
Inclusion criteria for PDG were: diagnosis of idiopathic
PD and to present Hoehn & Yahr stadium I, II or III. In
addition, both groups should be able to walk by them-
selves, have a normal cognitive state (i.e. score > 25) ac-
cording to the Minimental test adapted for PD [10],
symmetry in lower limb length (< 1 cm), and at least two
months of sedentary life and without having attended
physiotherapy sessions Exclusion criteria for both groups
were the presence of another neurological or symptomatic
musculoskeletal disease (e.g. musculoskeletal pain), history
of trauma or surgery on the lower limbs, balance disorders
due to other diseases and uncontrolled chronic diseases
(e.g. hypertension or diabetes).
Procedures
The assessments were carried out at the Medicine De-
partment of the University of Valencia. PDG participants
were evaluated in the on-medication state [4]. The as-
sessment session included first, a clinical interview to
record the main personal data of the participants and to
verify their cognitive state; second, an anthropometric
evaluation to record weight, height, and length of lower
limbs [11] used in the standardization of biomechanical
variables; and third, biomechanical assessment of gait at
a self-selected comfortable speed. All the participants
walked barefoot under all conditions tested to avoid the
damping provided by the different footwear of the par-
ticipants and therefore, prevent a confusing variable in
obtaining ground reaction forces. Five conditions were
randomly evaluated: i. single task (ST): walking without
secondary tasks with the attention focused only on walk-
ing performance, ii. visual DT: walking while checking
the time on an analog clock projected at the end of the
walkway, iii. Verbal DT: walking while telling the evalu-
ator the activities they had performed the previous day
in chronological order, iv. auditory DT: walking while
listening and recognizing different daily noises and, v.
motor DT: walking while carrying one glass in each
hand and repeatedly transferring their contents from
one to the other (beans). These tasks were intended to
simulate the action of looking at the time, talking with
another person, listening to the sounds of the environ-
ment and manipulating objects with hands while walk-
ing. All these tasks are representatives of daily life
activities, which provide external validity to the study
and concur with skills previously studied [4, 12]. During
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DT gait, participants were urged to focus attention on
the secondary task through all the way walking.
Biomechanical gait assessment
Gait assessment was carried out in a corridor 10 m long
and data were registered using 3D photogrammetry with
12 smart cams (Kinescan/IBV software, Biomechanical
Institute of Valencia, Valencia, Spain, version 5.3.0.1)
and two force platforms (Dinascan/IBV Biomechanical
Institute of Valencia, Valencia, Spain). A valid repetition
is one in which the patient performs at least five
complete strides along the corridor and where one
complete and isolated footprint (rigth or left) from the
third stride coincide with the dynamometric platform lo-
cated in the center of the corridor. The previous and
subsequent strides were discarded to avoid acceleration
and deceleration phases, at the beginning and at the end
of the gait, respectively. For each of the five evaluated
walking conditions, 10 repetitions were performed, five
with each foot, to later use the average of these. Partici-
pants were allowed to rest between repetitions, sitting
on a stool for less than three minutes, when fatigue was
reported.
The biomechanical model was composed of 35 land-
marks located in specific anatomical points on both sides
of the body: i. the spinous process of the seventh cervical
vertebra, ii. the acromioclavicular joint, iii. The posterosu-
perior iliac spine, iv. the anterior-superior iliac spine, v.
the greater trochanter of the femur, vi. the anterior vertex
triangle forming the thigh segment, vi. the medial condyle
of the knee, vii. The lateral condyle of the knee, viii. The
posterior vertex triangle of the leg segment, ix. the medial
malleolus of the ankle, x. lateral malleolus of the ankle, xi.
the posterior surface of calcaneus, xii. The tuberosity of
fifth metatarsal and xiii. Cuboids. For suitable biomechan-
ical modeling, the patient’s clothing included shorts,
sleeveless shirt and slip-on paddings (with the top of the
foot uncovered). Before recording gait, participants were
allowed to walk in the corridor (ST condition) to
familiarize themselves with the test.
Outcomes
For calculation of biomechanical variables based on the
data exported from the photogrammetry system and the
dynamometric platform, the software was programmed
with Matlab (MathWorks, MA, USA, version R2016b).
The average of these dependent variables was calculated
from the 10 repetitions for each condition: i. Velocity:
distance travelled by the body per unit of time (m/s), ii.
Stride length: distance measured between two consecu-
tive heel strikes of the same foot (i.e. two steps) (m), iii.
Cadence: number of steps taken in a minute (steps/min),
iv. Double support time: the sum of the amount of time
in which there is double-limb support in a gait cycle (%),
v. Ankle range: range of motion (ROM) that corresponds
to the sum of the maximum angle of plantar flexion and
maximum angle of dorsiflexion of the foot (°), vi. Hip
flexion: maximum flexion angle reached by the hip joint
during the swing phase of the gait cycle (°), vii. Hip ex-
tension: maximum extension angle reached by the hip
joint during the stance phase of the gait cycle (°), viii.
Weight-acceptance force: first peak of the vertical com-
ponent curve of reaction forces corresponding to the
maximal weight-acceptance (N), ix. Midstance force:
minimum value between the two force peaks of the ver-
tical component curve of reaction forces corresponding
to the midstance of the gait cycle (N), x. Braking force:
first negative peak of anteroposterior component curve
of reaction force that corresponds to the braking (N).
In addition, to inform about the degree of interference
of dual tasks during gait, the Dual-task cost was calcu-
lated as the percentage measure of performance decline
observed under DT conditions (Eq. 1) [4, 13]. Negative
values mean a decrease in the value measured during
the dual-task compared with the single-task condition.
Likewise, the same equation was used to describe the
performance of PDG with respect to the HG partici-
pants, which was defined as the Performance of parkin-
sonian gait (PPgait). When the PPgait percentage (Eq. 2)
was negative, it meant that the PDG had registered
lower values in the variable analyzed than the HG, while
positive PPgait indicated that the PDG has recorded
higher values than the HG. For the calculation of both
equations, the mean values obtained in each outcome
and group were used.
DT cost %ð Þ ¼ ST score−DT scoreð Þ
ST score
 100
Equation 1: Dual-task cost. Interference rate of dual
tasks during gait.
PPgait %ð Þ ¼ EPG score−HG scoreð Þ
EPG score
 100
Equation 2: Performance of parkinsonian gait. Impair-
ment of the group with Parkinson’s disease compared to
the healthy group.
Data analyses
Statistical analyses were performed using IBM SPSS v.24
(SPSS Inc., Chicago, IL, USA). Standard statistical
methods were used to obtain the mean and standard de-
viation (SD). Also, as descriptive results, the confidence
interval, PPgait percentage, and DT cost were calculated.
A two-factor mixed Multivariate analysis of variance was
conducted to analyze the effect of within-subject factor
conditions with five categories (ST, visual DT, verbal
DT, auditory DT, and motor DT) and between-subject
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factor group with two categories (i.e. PDG and HG) on the
dependent biomechanics variables. Some of these variables
were standardized according to anthropometric data, con-
cretely, ‘stride length’, which was standardized by the lower
limb length, and ground reaction force variables were stan-
dardized according to the weight of the participants.
When significant factor effects were found, the Bonfer-
roni correction, provided by the statistics package, was used
for pairwise comparisons. Differences were declared statisti-
cally significant if p < 0.05 and the 95% confidence interval
(CI) of the pairwise mean differences was reported.
To check for differences between the demographic
outcomes between groups, multivariate analysis with
one-way between-subject factor group was conducted.
Further, to demonstrate differences in gender between
groups, a chi-square test was used.
Results
Participants
Eighty-three participants completed this study. Their
characteristics are shown in Table 1. No significant dif-
ferences were observed between groups in age, weight,
height, body mass index (BMI), leg length or gender
(p > .05). Throughout the evaluation, the PD participants
did not present disorientation in any of the dual-task
cognitive conditions or apparent loss of memory during
the verbal dual-task condition.
Main demographic data for Parkinson’s disease group
(PDG) and healthy control (HG). Range, mean, standard
deviation (SD) and frequency are shown. NA: not applic-
able. BMI: body mass index. Differences between groups
from multivariate analysis with one-way between-subject
factor group are reported with 95% CI and the difference
between Gender from chi-square test are indicated by
the p value (statistically significant differences p < .05). *
Indicates statistically significant effects.
The interaction effect between condition and group factor
was statistically significant (p < .05) on double support time,
ankle range and midstance force outcomes (Table 2). This
indicates that the gait patterns of both groups varied in a
different way across the conditions evaluated. For the rest
of the outcomes analyzed, the factors had an isolated effect
(p < .05), indicating that the patterns of velocity, stride
length, cadence, hip flexion, weight-acceptance and break-
ing forces were similar for both groups through the condi-
tions evaluated (Table 2). On the maximum hip extension
variable, no significant effect was observed (p > .05).
For each effect, the value of the F ratio (F), the number
of degrees of freedom of factor and error, the p-value
and the eta square are shown. * Indicates statistically sig-
nificant effects (p < .05).
Dual-task interference during gait
Post-hoc analyses showed that the performance of both
groups for the ST condition was higher than visual DT
(p < .05) only in stride length, double support time and brak-
ing force (Fig. 1), which represented a DT cost for PDG of
6.19, − 7.16% and 12.59%, respectively (Table 3). In addition,
the same behavior with respect to these two conditions was
observed in PDG participants, who had a significant decrease
in range of ankle motion during the visual DT (DT cost:
6.48%), while HG participants showed a deterioration in hip
flexion outcome (p < .05). In velocity, cadence and both
vertical forces measured, the performance of participants
was similar in both, visual DT and ST condition (p > .05).
Regarding the verbal, auditory and motor dual-tasks, a
significant worsening of gait velocity, stride length,
double support time, midstance and braking forces were
observed in both groups (p < .05), shown in Fig. 1 and
Table 1 Clinical and demographical variables of participants
PDG HG Between-groups
Range Mean (SD) Range Mean (SD) CI (95%)
Age (years) 44–79 66.72 (7.50) 43–83 66.60 (8.75) −2.98 to 4.69
Weight (kg) 43–99 70.45 (12.13) 50–103 68.43 (12.15) −6.24 to 4.97
Height (m) 1.44–1.76 1.61 (.07) 1.42–1.82 1.58 (.08) −.07 to .00
BMI 16.37–39.57 26.51 (4.63) 21.93–38.77 27.22 (4.00) −1.28 to 2.69
Leg length (m) 78–97 85.84 (4.52) 73–99 85.34 (4.99) −3.31 to 1.20
Evolution (years) 1–23 5.78 (4.67) NP NP
Frequency (%) Frequency (%) p-value
Hoehn & Yahr scale I:4 10 NA NA –
II:9 22.5 NA NA –
III:27 67.5 NA NA –
Gender Male: 17 42.5 Male: 15 34.88 .47
Female: 23 57.5 Female: 28 65.12
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Table 3. In fact, the highest DT cost % of both, PDG
and HG, were observed in these outcomes, mainly for
verbal and motor tasks (Table 3), reaching in the PDG
participants a verbal DT cost of 25% during the per-
formance of the braking force. Besides these variables, in
the weight-acceptance force and cadence, we observed a
deterioration in the dual conditions mentioned only for
HG (p < .05), whereas the PDG presented a deterioration
of the ankle range under these same dual-tasks. With re-
spect to maximum hip flexion, although in the HG a de-
crease of the angle was observed in all dual conditions
(p < .05), in the PDG only this decrease was observed
during the verbal DT condition (p < .05).
In addition, significant differences between dual condi-
tions were observed, mainly between the visual DT and
another dual-task. Specifically, PDG performance was sig-
nificantly better during the visual DT condition than the
motor DT on stride length (mean difference: .08; 95% CI =
.00 to .17) and the verbal DT condition on double support
time (mean difference: 1.64; 95% CI = − 3.06 to −.21), mid-
stance (mean difference: 2.27; 95% CI = −.41 to −.03) and
braking forces (mean difference: .15; 95% CI = −.28 to
−.02). Also, we observed that the performance of the PDG
during verbal DT was significantly worse than the auditory
DT condition (p < .05) in double support time (mean dif-
ference: 1.47; 95% CI = .30 to 2.65), ankle range (mean dif-
ference: 1.64; 95% CI = − 3.16 to −.13) and braking force
(mean difference: .12; 95% CI = .01 to .22) outcomes. In a
different way, HG showed differences between dual condi-
tions chiefly in the midstance force, where they had worse
performance with verbal (mean difference: .28; 95% CI =
−.46 to −.10), auditory (mean difference: .36; 95% CI =
−.53 to −.18) and motor (mean difference: .20; 95% CI =
−.40 to −.01) tasks compared to the visual task.
Differences between groups for each condition
The differences between post-hoc analysis pairs of mea-
sures are shown in Table 4. The PDG participants had a
significantly worse performance than HG in all condi-
tions on gait velocity, stride length, double support time,
ankle range, hip flexion and midstance, weight-
acceptance and braking forces (p < .05). Conversely, a
similar hip extension gait pattern was observed for all
conditions evaluated and, besides, on cadence and ankle
range during auditory DT condition (p > .05).
These differences between PDG and HG are reflected
in the PPgait%, whose value changes according to the
analyzed variables. PDG participants walk slower and
perform a lower braking force, by more than 20% in re-
lation to the performance of HG participants. This def-
icit drops between 15 and 10% approximately in the
stride length, double support time, ankle range and mid-
stance force outcomes.
Discussion
This study analyzed how functional dual tasks affect parkin-
sonian gait and compared walking performance of people
with Parkinson’s disease with healthy older adults under
single and dual-task. To our knowledge, this is the first
study that uses functional dual-task in parkinsonian gait
assessment and analyzes kinematic and kinetic parameters,
Table 2 Main factors effects and their interactions on outcomes measures
Outcomes Condition Group Condition * Group
Velocity F (2.26; 183.66) = 15.98;
p = .00; ƞ2p = .17 *
F (1; 81) = 50.88;
p = .00; ƞ2p = .39 *
F (2.26; 183.66) = .33;
p = .85; ƞ2p = .04
Stride length F (2.70; 218.93) = 18.46;
p = .00; ƞ2p = .19 *
F (1; 81) = 28.07;
p = .00; ƞ2p = .26 *
F (2.70; 218.93) = 1.40;
p = .24; ƞ2p = .02
Cadence F (2.71; 219.95) = 4.50;
p = .00; ƞ2p = .05 *
F (1; 81) = 7.79;
p = .00; ƞ2p = .10 *
F (2.71; 219.95) = .64;
p = .57; ƞ2p = .00
Double support time F (3.66; 296.66) = 24.81;
p = .00; ƞ2p = .23 *
F (1; 81) = 42.35;
p = .00; ƞ2p = .34 *
F (3.66; 296.66) = 2.58;
p = .04; ƞ2p = .03 *
Ankle range F (3.47; 281.12) = 5.54;
p = .00; ƞ2p = .06 *
F (1; 81) = 12.24;
p = .00; ƞ2p = .13 *
F (3.47; 281.12) = 3.15;
p = .01; ƞ2p = .04 *
Hip extension F (2.73; 221.63) = 2.27;
p = .08; ƞ2p = .03
F (1; 81) = .32;
p = .56; ƞ2p = .00
F (2.73; 221.63) = 1.05;
p = .36; ƞ2p = .01
Hip flexion F (3.50; 283.80) = 8.57;
p = .00; ƞ2p = .10 *
F (1; 81) = 6.89;
p = .01; ƞ2p = .10 *
F (3.50; 283.80) = 1.67;
p = .16; ƞ2p = .02
Weight-acceptance force F (3.25; 263.55) = 7.04;
p = .00; ƞ2p = .10 *
F (1; 81) = 10.87;
p = .00; ƞ2p = .12 *
F (3.25; 263.55) = 2.23;
p = .08; ƞ2p = .03
Midstance force F (3.58; 290.46) = 26.69;
p = .00; ƞ2p = .25 *
F (1; 81) = 24.96;
p = .00; ƞ2p = .24 *
F (3.58; 290.46) = 2.54;
p = .04; ƞ2p = .03 *
Braking force F (2.98; 241.49) = 17.38;
p = .00; ƞ2p = .18 *
F (1; 81) = 28.34;
p = .00; ƞ2p = .26 *
F (2.98; 241.49) = 2.31;
p = .07; ƞ2p = .03
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Fig. 1 (See legend on next page.)
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in addition to spatiotemporal variables, which are the most
used in previous studies [4, 14].
Regarding dual-task interference, the gait of partici-
pants with PD and healthy controls significantly deterio-
rated when performing a dual-task but, this impairment
depended on the type of secondary task and outcomes
analyzed. First of all, we observed that the visual second-
ary task showed the least interference on gait in both
groups, since this was the only condition in which all
study participants showed a similar gait pattern to ST
condition, specifically in gait velocity, cadence and both
vertical forces. Indeed, both groups showed a better
walking with a visual task than with other secondary
tasks, although the differences between dual tasks were
more evident in the PDG. To explain why visual tasks
may interfere less during gait compared to other second-
ary tasks is complex due to sight is a common resource
for performing an appropriate walking pattern [15], con-
sequently, a vision interruption should be negative on
the gait of participants with PD. It is possible that visual
tasks are more common in daily life during gait perform-
ance and therefore, the participants were more accus-
tomed to this type of dual-task. On the other hand, the
type of visual task used in this study (to observe different
times of an analog clock projected on the wall at the end
of the walkway), allowed subjects to have a sufficiently
wide field of view. The visual tasks that are close to the
face or approach the visual objects to the subject (such
as looking at the mobile or the time on a wristwatch) re-
duce the visual field, which would deteriorate the bal-
ance. Conversely, to observe forward objects, allows to
get information about the environment in which we
walk, that is what occurred in our visual DT. Supporting
this theory, it was observed in previous studies that hav-
ing a reduced visual field in people with glaucoma
worsens the balance [16], as well as in people with PD
when they face a dynamic visual field [17].
By contrast, the secondary task that most interfered
with gait was not the same for both groups. For HG, the
interference caused by verbal, auditory and motor sec-
ondary tasks was similar between the measured out-
comes, that is, no significant differences were observed
between the dual conditions beyond the differences ob-
served with visual tasks and the percentages of DT cost
are similar between them.
Nevertheless, participants with PD showed the most
interference on gait with the verbal and motor secondary
tasks, specifically in the outcomes where the interaction
of the factors analyzed in this study was statistically sig-
nificant (double support time, ankle range and mid-
stance force), besides of braking force. That is to say, the
PD participants achieved a better gait with a visual or
auditory task than with verbal or motor secondary tasks.
The verbal tasks could be more complex to perform
than other secondary tasks due to the subcomponents
involved: lexicon, message planning, message extension
and oral motor movement. From there, the motor part
of speech produces the largest interference in the con-
text of the dual-task paradigm [18], so it could be using
resources from other cortical areas that are hyper-
activated in parkinsonian gait, as a compensation for the
lack basal ganglia movement regulation [19] such as the
frontal lobe [20]. Likewise, basal ganglia have direct con-
trol over the motor function [8]; accordingly, two con-
current motor tasks could be competing for the same
neural resources [4], which would explain the high inter-
ference of the motor task with the arms. Future studies
should differentiate the benefits of gait rehabilitation
with high-interference and low-interference secondary
task. Moreover, the progression of gait exercises that
starts with secondary visual tasks that allow having a
wide visual field should be considered.
Concerning the second objective of this study, the re-
sults showed that the performance of PDG is signifi-
cantly lower than the performance by HG, in all the
outcomes except for hip extension during the stance
phase of the gait cycle. However, the lower performance
of the PDG was not always the same for all the variables,
which was evidenced by the PPgait percentage. While in
velocity and braking force the PPgait percentage was
greater than 20%, in the stride length, double support
time, ankle range, hip flexion and midstance force out-
comes, the PPgait percentage varied between approxi-
mately 10 and 15%. On the other hand, a performance
below or around 5% was observed in cadence and
weight-acceptance force.
In general, it seems interesting to note that PPgait is
especially high during the motor condition when observ-
ing most of the variables analyzed, reaching a 34% deficit
in the braking force while developing the motor DT.
This could indicate that there are aspects of Parkinson-
ian gait that are more affected than others and that the
context of the gait could influence it as well. An example
of this is that people with PD have difficulty to take large
(See figure on previous page.)
Fig. 1 Gait performance of both groups in all conditions of study. Mean and standard deviation represented with the vertical lines for the
Parkinson’s disease group (PDG, dashed line) and the healthy group (HG, continuous line) for the Single-task (ST), visual (viDT), verbal (veDT),
auditory (aDT) and motor (mDT) dual-task conditions. The upper horizontal black lines represent the statistical differences between single-task
and dual-task conditions, while the differences between dual conditions are represented in blue. The letters below each horizontal line indicate
statistically significant differences of the Parkinson’s disease group (a) and statistically significant differences of the healthy group (b)
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DT cost 95% CI DT cost 95% CI
Velocity Visual −7.49 −.04 to .19 − 6.09 −.04 to .18
Verbal −14.97 .07 to .22* −12.70 .08 to .22*
Auditory −12.20 .06 to .17* −12.19 .09 to .20*
Motor −15.09 .08 to .20* −10.34 .06 to .18*
Stride length Visual −6.19 .01 to .14* −4.95 .01 to .13*
Verbal −10.48 .07 to .18* −7.61 .05 to .15*
Auditory −7.40 .03 to .15* −6.39 .03 to .14*
Motor −13.0 .08 to .25* −6.74 .01 to .18*
Cadence Visual −.32 −5.12 to 5.82 −3.37 −1.22 to 9.33
Verbal −4.33 −1.12 to 10.73 −6.19 1.73 to 13.16*
Auditory −2.07 −4.06 to 8.65 −5.72 .75 to 13.01*
Motor −2.28 −3.04 to 8.10 −3.68 −.94 to 9.80
Double support time Visual 7.16 −3.39 to −.89* 5.96 −2.77 to −.36*
Verbal 12.63 −5.25 to −2.32* 7.30 −3.33 to −.50*
Auditory 7.70 −3.28 to −1.32* 8.56 −3.19 to − 1.30*
Motor 10.66 −4.57 to −1.81* 9.19 −3.74 to −1.08*
Ankle range Visual −6.48 .00 to 2.33* −4.16 −.29 to 1.95
Verbal −8.68 .51 to 2.61* −2.47 −.51 to 1.50
Auditory .45 −1.66 to 1.50 −.93 −1.34 to 1.71
Motor −11.24 .59 to 3.46* −.99 −1.18 to 1.57
Hip extension Visual −5.70 −2.07 to .98 3.01 −1.19 to 1.75
Verbal −8.87 −2.35 to .64 .61 −1.39 to 1.50
Auditory −10.01 −2.40 to .47 −1.47 − 1.52 to 1.25
Motor −13.84 −2.97 to .30 − 2.37 − 1.80 to 1.36
Hip flexion Visual −1.94 −1.13 to 2.22 −5.44 .15 to 3.39*
Verbal −5.15 .17 to 2.69* −5.66 .62 to 3.05*
Auditory −2.23 −.78 to 2.03 −6.51 .75 to 3.47*
Motor −4.37 −.03 to 2.47 − 6.71 .97 to 3.39*
Weight-acceptance force Visual −1.24 −.19 to .39 −2.55 −.00 to .56
Verbal −1.20 −.11 to .35 −3.80 .19 to .65*
Auditory −1.18 −.13 to .38 − 3.95 .19 to .69*
Motor −.99 −.17 to .39 −2.42 .01 to .56*
Midstance force Visual 1.37 −.34 to .09 2.42 −.40 to .02
Verbal 4.16 −.58 to −.11* 6.09 −.70 to −.24*
Auditory 2.91 −.49 to −.01* 7.02 −.78 to −.31*
Motor 3.47 −.54 to −.05* 4.75 −.63 to −.16*
Braking force Visual −12.59 −.24 to −.04* − 10.03 −.25 to −.05*
Verbal −25.30 −.42 to −.17* − 11.96 −.30 to −.06*
Auditory − 14.82 −.29 to −.05* − 16.67 −.37 to −.14*
Motor − 17.59 −.39 to −.04* − 11.97 −.36 to −.02*
Differences between single-task and dual-tasks conditions for each group from post-hoc analysis are shown with de 95% confidence interval (95% CI). * Indicates
significant statistical differences between single-task and dual-task condition (p < .05). The dual-task cost was calculated with eq. 1. Negative percentages mean a
decrease in the value measured during the dual-task compared with the single-task condition
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steps while the ability to control cadence is maintained
or deteriorates more progressively [21, 22].
Further, the results of the kinematic variables are in
consonance with these results. We have observed that
participants with PD only differed from control partici-
pants in the ankle range and hip flexion, achieving a
similar maximum hip extension. Other authors have
previously observed a decreased plantar flexion in the
first stages of PD (Hoehn & Yahr II) [5], while in more
advanced stages (Hoehn & Yahr II.V and III), alterations
of ankle dorsiflexion would further reduce ankle ROM
[11]. In our study, although we see a small but signifi-
cant decrease in the ankle range compared to the con-
trol participants, we cannot assure if it is due to the
limited plantar flexion or dorsiflexion. On the other
hand, the deficit in hip flexion during the swing phase of
gait cycle was also observed for other authors [21, 23]
and would suggest a higher risk of falls in people with
PD without training. Hip flexion occurs actively, facili-
tating the oscillation of the limb and helping to prevent
foot drag during the swing phase. However, a poor hip
flexion could favor a “shuffling gait” [24] which restrain
people with PD from taking long and high steps. Despite
these negative findings, we do not observe a decrease in
the maximum hip extension reached on stance phase of
gait cycle, which coincides with the observations of other
studies during gait [5] both ON and OFF phase of the
medication [23]. Finally, we observed a significant decrease
in weight-acceptance and braking force and greater mid-
stance force of the PDG compared to the HG. The influ-
ence that gait velocity has on the braking force [25] and on
vertical forces [26], could explain these differences with the
healthy group. In fact, high speeds (1.1–1.4m/s) generate a
higher vertical force in the loading response phase and
lower in the midstance than low speeds (.83m/s). In other
words, the PD participants in our study tended to
homogenize the vertical force curve compared to the con-
trol participants, which has been previously evidenced in
conditions with and without medication effects [27].
Table 4 Gait performance differences between groups
Outcomes Condition PPgait% 95% CI
Velocity Single −22.03 .14 to .29*
Visual −23.88 .13 to .30*
Verbal − 25.29 .13 to .29*
Auditory −22.04 .11 to .27*
Motor −28.86 .16 to .32*
Stride length Single −12.60 .1 to .25*
Visual −14.09 .1 to .26*
Verbal −16.21 .12 to .27*
Auditory −13.82 .1 to .25*
Motor −20.78 .14 to .35*
Cadence Single −8.48 5.44 to 13.36*
Visual −5.16 .85 to 12.25*
Verbal −6.37 .1 to 13.24*
Auditory −4.43 −2.1 to 11.72
Motor − 6.92 .83 to 14.18*
Double support time Single 12.38 −5.0 to −2.42*
Visual 13.37 −5.8 to −3.76*
Verbal 16.53 −7.41 to −3.75*
Auditory 11.68 −5.21 to −2.33*
Motor 13.55 −6.26 to −2.73*
Ankle range Single −10.62 .23 to 3.60*
Visual −13.36 .54 to 4.00*
Verbal −18.13 1.4 to 4.60*
Auditory −9.10 −.15 to 3.45
Motor −23.38 2.24 to 5.25*
Hip extension Single 2.84 −1.88 to 2.42
Visual −6.13 −2.18 to 1.10
Verbal −7.27 −2.32 to 1.05
Auditory −6.39 −2.21 to 1.11
Motor −10.09 −2.5 to .82
Hip flexion Single −16.49 1.4 to 7.80*
Visual −12.33 .32 to 6.43*
Verbal −15.86 1.35 to 7.05*
Auditory −11.39 .24 to 6.00*
Motor −13.63 .67 to 6.61*
Weight-acceptance force Single −3.17 .29 to 1.06*
Visual −1.80 .11 to .89*
Verbal −0.46 .10 to .65*
Auditory −0.28 .05 to .66*
Motor −1.68 .28 to .77*
Midstance force Single 11.66 −1.09 to −.46*
Visual 10.75 −1.03 to −.39*
Verbal 10.03 −.92 to −.39*
Auditory 8.13 −.75 to −.21*
Table 4 Gait performance differences between groups
(Continued)
Outcomes Condition PPgait% 95% CI
Motor 10.57 −.96 to −.40*
Braking force Single −25.66 −.53 to −.18*
Visual −29.35 −.51 to −.17*
Verbal −48.10 −.64 to −.29*
Auditory −22.93 −.43 to −.12*
Motor −34.23 −.50 to −.26*
Differences between groups for each condition evaluated from post-hoc
analysis are shown with the 95% confidence interval (95% CI). * Indicates
significant statistical differences between groups (p < .05). PPgait: Performance
of parkinsonian gait (%), negative values mean Parkinson’s disease group had
registered lower values in the variable analyzed than the healthy group
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Additionally, the decreased braking capacity observed in
some people with PD reflects impaired postural control
during gait [28] and it has been pointed out that this could
be due to nondopaminergic lesions.
The results of this study, however, are obtained from par-
ticipants with normal cognitive status, so future studies are
needed to establish how functional tasks, secondary to gait,
could interfere in people with PD in advanced stages and
cognitive impairment. Another limitation of the study is
that we used only day-to-day tasks in the evaluation, conse-
quently, it is possible that the interference on the gait is in-
fluenced by the amount of daily practice of the selected
tasks. Further, regarding the statistics, we should take into
consideration that the Bonferroni adjustments conducted
in the post-hoc comparisons could lead to an increase of
the type II error [29]. Moreover, we have not studied
whether different aspects of gait could have different neural
control, which would explain the larger impact it has on
some variables than on others. Otherwise, the participants
were assessed in their bare feet to avoid the heterogeneity
in the damping provided by the different footwear of the
participants and therefore, prevent any confusion by that
potential variability in the calculation of the ground reac-
tion forces. However, it could affect the external validity,
since in daily life, walking is conducted with shoes.
On the contrary, we conducted several DT conditions
trying to cover the assessment of gait interference by sec-
ondary tasks, as it happens in habitual environments with
multiples cognitive and motor demands. To assure face val-
idity, the tests included were agreed by all the researchers
and aligned with previous studies in which gait assessment
was conducted [4, 12]. However, we did not analyze the
construct validity of the gait assessment procedure.
Therefore, we could not explore the homogeneity of
the variables included in the conditions. Future works
should analyze the construct validity of the outcomes
included in the study to ensure that the gait pattern
construct is being assessed.
Conclusion
In untrained participants with PD, verbal and motor sec-
ondary tasks affect gait adversely and significantly, while
auditory and visual tasks interfere to a lesser extent. Un-
trained people with PD have a poorer gait performance
than their healthy counterparts both for the spatiotem-
poral, kinematic and kinetic variables analyzed, with the
exception of the maximum hip extension during the
stance phase of the gait cycle.
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